Why is "Cyclophosphamide" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-13 06:10:31
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome, ANCA-associated vasculitis, and following organ transplant, among other conditions. It is taken by mouth or injection into a vein.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003) | Blood Cancer Journal - Nature
-
Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL - Business Wire
-
Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxane With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer - The ASCO Post
-
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin - NEJM
-
Pembrolizumab/Cyclophosphamide Combo Yield Efficacy, Safety in Ovarian Cancer - Targeted Oncology
-
Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights - Frontiers
-
Nexus Pharmaceuticals Launches New Cyclophosphamide Injection - National Today
-
Frontline Metronomic Cyclophosphamide Fails to Provide Advantage Over Doxorubicin in Soft Tissue Sarcoma - OncLive
-
Can Post Transplant Cyclophosphamide Cut GVHD Risk? - City of Hope
-
Posttransplant cyclophosphamide in HLA-matched peripheral blood transplantation: what’s next? - ScienceDirect.com
-
Impact of Posttransplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 Years and Older: An Update from BMT CTN 1703 - CancerNetwork
-
Rituximab matches cyclophosphamide in inducing AAV remission: Review - ANCA Vasculitis News
-
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial - Nature
-
Implications of Cyclophosphamide, Methotrexate, and 5-Flurouracil Chemotherapy on Hippocampal-Dependent Cognition and Gut-Microbiome: Revised - Frontiers
-
Cyclophosphamide and Cyclosporin for GVHD Prevention - NEJM
-
Adding Olanzapine to Triplet Antiemetics Post–Anthracycline/Cyclophosphamide Chemotherapy - The ASCO Post
-
A density functional theory study of cyclophosphamide and purinethol adsorption on a covalent triazine framework (CTF-2) for drug delivery applications - Nature
-
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party - Nature
-
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation - Nature
-
Ineffectiveness of pioglitazone in cognitive impairment induced by cyclophosphamide, methotrexate, and fluorouracil via oxidative stress and neuroinflammation - Frontiers
-
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adults - Frontiers
-
Protective Efficacy of Protocatechuic Acid Against Cyclophosphamide-Induced Nephrotoxicity in Small White Mice - Wiley Online Library
-
Cyclophosphamide—A promising solution for refractory ICANS - Wiley Online Library
-
Prophylactic Pegfilgrastim Versus On-Demand Filgrastim During Docetaxel and Cyclophosphamide Chemotherapy in Early-Stage Breast Cancer: A Retrospective Analysis - Cureus
-
Protective effects of coenzyme Q10 against cyclophosphamide induced ovarian damage in rats - Nature
-
Pembrolizumab combined with lenvatinib and metronomic cyclophosphamide in platinum-resistant ovarian cancer: a case report of durable clinical response - Frontiers
-
Dietary Carvacrol Attenuates Cyclophosphamide-Induced Neurotoxicity: Implications for Food-Derived Neuroprotection and Molecular Mechanisms - Wiley Online Library
-
Cyclosporin/Cyclophosphamide Is a Potential New SOC in GVHD Management - CancerNetwork
-
Nebivolol Mitigates the Pro-Oxidative and Pro-Inflammatory Effects of Cyclophosphamide in the Heart - Wiley Online Library
-
Novel Vaccine Combo Shows Responses in Recurrent Epithelial Ovarian Cancer - CancerNetwork
-
ALPHA3 Trial of Cema-Cel in LBCL Proceeds With Fludarabine/Cyclophosphamide Lymphodepletion Regimen - OncLive
-
Cyclophosphamide-Based GVHD Prophylaxis May Improve Survival in HSCT - CancerNetwork
-
Bone-protective effects of deer-hide gelatin in cyclophosphamide-induced osteoporosis rats - Frontiers
-
Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation - Wiley Online Library
-
Safranal Alleviates Cyclophosphamide Induced Testicular Toxicity in Rats - Cellat - 2025 - Food Science & Nutrition - Wiley Online Library
-
METROPHOLYS Trial: MC vs DOXO in Elderly STS - Oncodaily
-
Cryptosporidium Diarrhea in a Patient With Class IV Lupus Nephritis on Cyclophosphamide: An Underreported Case - Cureus
-
Posttransplant Cyclophosphamide/Abatacept Reduces Moderate, Severe GVHD Compared With SOC - Targeted Oncology
-
Improved Lung Function With Cyclophosphamide and Rituximab in a Case of Shrinking Lung Syndrome - Cureus
-
Tocilizumab combined with cyclophosphamide for the treatment of rapidly progressive refractory systemic sclerosis with predominant cardiac involvement: A case report - Frontiers
-
Nexus Wins Patent Litigation for Injectable Cyclophosphamide, Paving Way for Generic - Business Wire
-
Cyclophosphamide for GVHD Continues to Extend Stem-Cell Transplant Eligibility - MedPage Today
-
Allogeneic hematopoietic cell transplantation with a combination of posttransplantation bendamustine and cyclophosphamide in refractory myeloid neoplasms - Wiley
-
Tocilizumab combined with cyclophosphamide for the treatment of rapidly progressive refractory systemic sclerosis with predominant cardiac involvement: a case report - Frontiers
-
Monzr AlMalki: Thrilled to Share ACCESS Study Publication on Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis - Oncodaily
-
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome - NEJM Evidence
-
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results | Blood Cancer Journal - Nature
-
Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation - Nature
-
Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma - Nature
-
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet
-
Preliminary proteomic analysis of mouse lung tissue treated with cyclophosphamide and Venetin-1 - Nature
-
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet
-
FDA Approves Ready-to-Dilute Cyclophosphamide Injection for Various Cancers - OncLive
-
Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids - Nature
-
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis - NEJM
-
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer - Nature
-
Protective effects of hesperidin in cyclophosphamide-induced parotid toxicity in rats - Nature
-
Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC - Frontiers
-
Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs - Nature
-
BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis - Nature
-
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect - Nature
-
Insights on cyclophosphamide metabolism and anticancer mechanism of action: A computational study - Wiley Online Library
-
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis - NEJM
-
Cyclophosphamide Induces the Ferroptosis of Tumor Cells Through Heme Oxygenase-1 - Frontiers
-
Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma - Nature
-
Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052) - Nature
-
Acute Liver Injury Caused by Cyclophosphamide in a Patient With Factor VIII Deficiency: A Rare Presentation - Cureus
-
Single Cell Map of Human Azoospermia Testis Caused by Cyclophosphamide Chemotherapy - Nature
-
Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision - ScienceDirect.com
-
Ready-to-Dilute Cyclophosphamide Injections Obtain FDA Approval - Oncology Nursing News
-
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the Eur - Wiley
-
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma | Blood Cancer Journal - Nature
-
Single-cell analysis reveals urothelial cell heterogeneity and regenerative cues following cyclophosphamide-induced bladder injury - Nature
-
Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation - Frontiers
-
Cyclophosphamide versus Placebo in Scleroderma Lung Disease - NEJM
-
Removing Mesna From Cyclophosphamide Cycles in VAdriaC-IE for Ewing Sarcoma - Pharmacy Times
-
Dose-dense adjuvant therapy with epirubicin and cyclophosphamide effective for breast cancer - 2 Minute Medicine
-
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial | Journal of Clinical Oncology - ASCO Publications
-
Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study - Nature
-
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma - Nature
-
Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease - Frontiers
-
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network - Nature
-
Life-Threatening Haemorrhagic Enterocolitis: A Rare Complication of Chemotherapy With Cyclophosphamide - Cureus
-
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis - NEJM
-
Lutein isolated from Scenedesmus obliquus microalga boosts immunity against cyclophosphamide-induced brain injury in rats - Nature
-
Call for public consultation: Target product profile for paediatric formulations of cyclophosphamide, etoposide, mercaptopurine, methotrexate, procarbazine and temozolomide - World Health Organization (WHO)
-
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis - NEJM
-
Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics - El-Serafi - 2024 - Advances in Pharmacological and Pharmaceutical Sciences - Wiley Online Library
-
Use of cyclophosphamide regimen found effective in hard-to-treat MG - Myasthenia Gravis News
-
TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice - Nature
-
Low-Dose Cyclophosphamide Induces Nerve Injury and Functional Overactivity in the Urinary Bladder of Rats - Frontiers
-
Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma - Wiley Online Library
-
Orca-T Is Associated With Retrospective OS Improvement vs Post-Transplant Cyclophosphamide in Advanced Hematologic Malignancies - OncLive
-
Evidence of apoptosis as an early event leading to cyclophosphamide-induced primordial follicle depletion in a prepubertal mouse model - Frontiers
-
Rituximab, Cyclophosphamide Combo Safe in Pediatric Patients - Medscape
-
Preventing GVHD after a Stem Cell Transplant - National Cancer Institute (.gov)
-
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial - The Lancet
-
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT) - Nature
-
Cyclophosphamide, Bortezomib, and Dexamethasone and Severe Systolic Heart Failure: A Case Report - Cureus
-
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia - Wiley
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.